REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,629,000 | +27.3% | 78,719 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,280,000 | +20.2% | 78,950 | +0.8% | 0.00% | +100.0% |
| Q2 2016 | $1,065,000 | -6.4% | 78,313 | +20.2% | 0.00% | 0.0% |
| Q1 2016 | $1,138,000 | -47.8% | 65,170 | +2.2% | 0.00% | -66.7% |
| Q4 2015 | $2,179,000 | +32.5% | 63,776 | +15.3% | 0.00% | +50.0% |
| Q3 2015 | $1,645,000 | -7.6% | 55,292 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $1,780,000 | +219.0% | 55,668 | +106.6% | 0.00% | +100.0% |
| Q1 2015 | $558,000 | +24.0% | 26,941 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $450,000 | -11.6% | 26,536 | +0.8% | 0.00% | 0.0% |
| Q3 2014 | $509,000 | -30.3% | 26,314 | +22.5% | 0.00% | 0.0% |
| Q2 2014 | $730,000 | +20.7% | 21,483 | +11.9% | 0.00% | 0.0% |
| Q1 2014 | $605,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |